Ronald M Bukowski. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Benzenesulfonates/adverse effectsBenzenesulfonates/therapeutic useCarcinoma, Renal Cell/drug therapyCarcinoma, Renal Cell/secondaryDrug Eruptions/etiologyFoot Diseases/chemically inducedHand Dermatoses/chemically inducedHumansIndoles/adverse effectsIndoles/therapeutic useKidney Neoplasms/drug therapyKidney Neoplasms/pathologyNiacinamide/analogs & derivativesParesthesia/chemically inducedPhenylurea CompoundsProtein Kinase Inhibitors/adverse effectsProtein Kinase Inhibitors/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsPyridines/adverse effectsPyridines/therapeutic usePyrroles/adverse effectsPyrroles/therapeutic useSorafenibSunitinib
Substances： See more » BenzenesulfonatesIndolesPhenylurea CompoundsProtein Kinase InhibitorsPyridinesPyrrolesNiacinamideSorafenibProtein-Tyrosine KinasesSunitinib
Year: 2009 PMID： 19213661 DOI： 10.3816/CGC.2009.n.001
Source DB: PubMed Journal: Clin Genitourin Cancer ISSN： 1558-7673 Impact factor: 2.872